COVID-19: Nasal vaccine could be a game-changer if it provides mucosal immunity, says AIIMS epidemiologist
Jan 30, 2022
New Delhi [India], January 30 : As Hyderabad-based drug maker Bharat Biotech has got regulatory approval to conduct Phase-3 clinical trials of its intranasal...